Why is Jagsonpal Pharma falling/rising?

As of 10-Nov, Jagsonpal Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 213.20, which reflects a decrease of 2.9 or 1.34%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.64% over the past week. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite the company declaring positive results for the last six consecutive quarters, including a significant increase in operating profit, the stock's valuation appears expensive with a Price to Book Value of 5.9. Furthermore, the lack of domestic mutual fund investment, which stands at 0%, may indicate a lack of confidence in the stock's current price.
In the broader market context, the stock has significantly underperformed compared to the benchmark, with a return of -10.03% over the past year, while the market has generated a return of 3.81%. This stark contrast highlights the stock's struggles, particularly as it has also underperformed the Sensex over various periods, including a 1-month return of -3.38% compared to the Sensex's 1.25%. The falling investor participation, evidenced by a 33.49% drop in delivery volume, further exacerbates the situation, suggesting that market sentiment is not favorable for Jagsonpal Pharmaceuticals at this time.